BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28745845)

  • 1. Sedative-hypnotic drug withdrawal syndrome: recognition and treatment [digest].
    Santos C; Olmedo RE; Kim J
    Emerg Med Pract; 2017 Mar; 19(3 Suppl Points & Pearls):S1-S2. PubMed ID: 28745845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sedative-Hypnotic Drug Withdrawal Syndrome: Recognition And Treatment.
    Santos C; Olmedo RE
    Emerg Med Pract; 2017 Mar; 19(3):1-20. PubMed ID: 28186869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sedative-Hypnotic Agents That Impact Gamma-Aminobutyric Acid Receptors: Focus on Flunitrazepam, Gamma-Hydroxybutyric Acid, Phenibut, and Selank.
    Doyno CR; White CM
    J Clin Pharmacol; 2021 Aug; 61 Suppl 2():S114-S128. PubMed ID: 34396551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABA systems, benzodiazepines, and substance dependence.
    Malcolm RJ
    J Clin Psychiatry; 2003; 64 Suppl 3():36-40. PubMed ID: 12662132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Withdrawal syndrome after abuse of GHB (Gamma-Hydroxybutyrate) and its physiological precursors - its relevance for child and adolescent psychiatrists].
    Zepf FD; Holtmann M; Duketis E; Maier J; Radeloff D; Schirman S; Wagner A; Poustka F; Wöckel L
    Z Kinder Jugendpsychiatr Psychother; 2009 Sep; 37(5):413-20. PubMed ID: 19739059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tiagabine withdrawal-emergent mania.
    Pushpal D; Shamshul HN
    Aust N Z J Psychiatry; 2006 Aug; 40(8):719. PubMed ID: 16866771
    [No Abstract]   [Full Text] [Related]  

  • 7. [Benzodiazepines to people with substance abuse problems?].
    Waal H; Bramness JG
    Tidsskr Nor Laegeforen; 2010 Mar; 130(6):610-2. PubMed ID: 20349006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and treatment of gamma butyrolactone withdrawal syndrome: a case report and review.
    Ghio L; Cervetti A; Respino M; Belvederi Murri M; Amore M
    J Psychiatr Pract; 2014 Jul; 20(4):294-300. PubMed ID: 25036586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sedative/hypnotic dependence: patient stabilization, tolerance testing, and withdrawal.
    Perry PJ; Alexander B
    Drug Intell Clin Pharm; 1986; 20(7-8):532-7. PubMed ID: 2874971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and management of insomnia.
    Byerley B; Gillin JC
    Psychiatr Clin North Am; 1984 Dec; 7(4):773-89. PubMed ID: 6542995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gamma-hydroxybutyrate withdrawal syndrome.
    Tarabar AF; Nelson LS
    Toxicol Rev; 2004; 23(1):45-9. PubMed ID: 15298492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abuse liability of barbiturates and other sedative-hypnotics.
    Morgan WW
    Adv Alcohol Subst Abuse; 1990; 9(1-2):67-82. PubMed ID: 2198786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of alcohol withdrawal.
    Erstad BL; Cotugno CL
    Am J Health Syst Pharm; 1995 Apr; 52(7):697-709. PubMed ID: 7627738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome.
    Coffey RJ; Edgar TS; Francisco GE; Graziani V; Meythaler JM; Ridgely PM; Sadiq SA; Turner MS
    Arch Phys Med Rehabil; 2002 Jun; 83(6):735-41. PubMed ID: 12048649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome-like reaction precipitated by antipsychotics in a patient with gamma-butyrolactone withdrawal.
    Eiden C; Capdevielle D; Deddouche C; Boulenger JP; Blayac JP; Peyrière H
    J Addict Med; 2011 Dec; 5(4):302-3. PubMed ID: 21817917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for valproate in the treatment of sedative-hypnotic withdrawal and for relapse prevention.
    Harris JT; Roache JD; Thornton JE
    Alcohol Alcohol; 2000; 35(4):319-23. PubMed ID: 10905994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. For publication: Tiagabine in the discontinuation of long-term benzodiazepine use.
    Oulis P; Masdrakis VG; Karapoulios E; Karakatsanis NA; Kouzoupis AV; Papadimitriou GN
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):122. PubMed ID: 19154218
    [No Abstract]   [Full Text] [Related]  

  • 18. Managing benzodiazepine withdrawal during pregnancy: case-based guidelines.
    Gopalan P; Glance JB; Azzam PN
    Arch Womens Ment Health; 2014 Apr; 17(2):167-70. PubMed ID: 24271083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The dangers of the sudden discontinuation of drugs].
    de Graeff PA
    Ned Tijdschr Geneeskd; 1985 Jun; 129(22):1034-9. PubMed ID: 2861575
    [No Abstract]   [Full Text] [Related]  

  • 20. Review of alcohol withdrawal in the hospitalized patient: management.
    Vincent WR; Smith KM; Winstead PS; Lewis DA
    Orthopedics; 2007 Jun; 30(6):446-9. PubMed ID: 17598488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.